Your browser doesn't support javascript.
loading
LIMIT: LIfestyle and Microbiome InTeraction Early Adiposity Rebound in Children, a Study Protocol.
De Giuseppe, Rachele; Loperfido, Federica; Cerbo, Rosa Maria; Monti, Maria Cristina; Civardi, Elisa; Garofoli, Francesca; Angelini, Micol; Maccarini, Beatrice; Sommella, Eduardo; Campiglia, Pietro; Bertuzzo, Laura; Chieppa, Marcello; Ghirardello, Stefano; Cena, Hellas.
Affiliation
  • De Giuseppe R; Laboratory of Dietetics and Clinical Nutrition, Department of Public Health, Experimental and Forensic Medicine, University of Pavia, Via Bassi 21, 27100 Pavia, Italy.
  • Loperfido F; Laboratory of Dietetics and Clinical Nutrition, Department of Public Health, Experimental and Forensic Medicine, University of Pavia, Via Bassi 21, 27100 Pavia, Italy.
  • Cerbo RM; Neonatal Unit and Neonatal Intensive Care Unit, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy.
  • Monti MC; Department of Public Health, Experimental and Forensic Medicine-Unit of Biostatistics and Clinical Epidemiology, University of Pavia, 27100 Pavia, Italy.
  • Civardi E; Neonatal Unit and Neonatal Intensive Care Unit, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy.
  • Garofoli F; Neonatal Unit and Neonatal Intensive Care Unit, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy.
  • Angelini M; Neonatal Unit and Neonatal Intensive Care Unit, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy.
  • Maccarini B; Laboratory of Dietetics and Clinical Nutrition, Department of Public Health, Experimental and Forensic Medicine, University of Pavia, Via Bassi 21, 27100 Pavia, Italy.
  • Sommella E; Department of Pharmacy, University of Salerno, Fisciano, 84084 Salerno, Italy.
  • Campiglia P; Department of Pharmacy, University of Salerno, Fisciano, 84084 Salerno, Italy.
  • Bertuzzo L; GlaxoSmithKline (GSK) Consumer Healthcare, Haleon Group, Via Zambeletti s.n.c. 20021 Baranzate, Italy.
  • Chieppa M; Department of Biological and Environmental Sciences and Technologies (DISTEBA), University of Salento, 73100 Lecce, Italy.
  • Ghirardello S; Neonatal Unit and Neonatal Intensive Care Unit, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy.
  • Cena H; Laboratory of Dietetics and Clinical Nutrition, Department of Public Health, Experimental and Forensic Medicine, University of Pavia, Via Bassi 21, 27100 Pavia, Italy.
Metabolites ; 12(9)2022 Aug 28.
Article de En | MEDLINE | ID: mdl-36144214
Childhood obesity is a strong predictor of adult obesity with health and economic consequences for individuals and society. Adiposity rebound (AR) is a rise in the Body Mass Index occurring between 3 and 7 years. Early adiposity rebound (EAR) occurs at a median age of 2 years and predisposes to a later onset of obesity. Since obesity has been associated with intestinal dysbiosis, we hypothesize that EAR could be related to early microbiome changes due to maternal/lifestyle changes and environmental exposures, which can increase the unhealthy consequences of childhood obesity. LIMIT is a prospective cohort study that aims at identifying the longitudinal interplay between infant gut microbiome, infant/maternal lifestyle, and environmental variables, in children with EAR vs. AR. Methods. The study evaluated 272 mother-infant pairs, enrolled at an Italian neonatal unit, at different time points (T0, at delivery; T1, 1 month; T2, 6 months; T3, 12 months; T4, 24 months; T5, 36 months after birth). The variables that were collected include maternal/infant anthropometric measurements, lifestyle habits, maternal environmental endocrine disruptor exposure, as well as infant AR. The LIMIT results will provide the basis for early identification of those maternal and infant modifiable factors on which to act for an effective and personalized prevention of childhood obesity.
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Observational_studies / Prognostic_studies / Risk_factors_studies Langue: En Journal: Metabolites Année: 2022 Type de document: Article Pays d'affiliation: Italie Pays de publication: Suisse

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Observational_studies / Prognostic_studies / Risk_factors_studies Langue: En Journal: Metabolites Année: 2022 Type de document: Article Pays d'affiliation: Italie Pays de publication: Suisse